2018-2023 Global Erythropoietin (EPO) Drugs Consumption Market Report

August 2018 | 130 pages | ID: 2EC36A805E9EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Erythropoietin (EPO) Drugs market for 2018-2023.

EPO is a naturally occurring hormone produced by cells in the kidneys that regulate the production of red blood cells in bone marrow.
Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO-stimulating agents as these diseases may cause anemia. To curb rising incidence of anemia, demand for erythropoietin drugs is expected to increase over the coming years.
Over the next five years, LPI(LP Information) projects that Erythropoietin (EPO) Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Erythropoietin (EPO) Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Epoetin-alfa
• Darbepoetin-alfa
• Epoetin-beta

Segmentation by application:

• Anemic indications
• Cancer
• Hematology
• Neurology
• Renal diseases

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Johnson & Johnson
• Celltrion
• Teva Pharmaceutical
• Amgen
• Roche
• LG Life Sciences
• Biocon
• Intas Pharmaceuticals
• Sun Pharmaceutical
• Dr. Reddy’s Laboratories

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Erythropoietin (EPO) Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Erythropoietin (EPO) Drugs market by identifying its various subsegments.
• Focuses on the key global Erythropoietin (EPO) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Erythropoietin (EPO) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Erythropoietin (EPO) Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Erythropoietin (EPO) Drugs Consumption 2013-2023
  2.1.2 Erythropoietin (EPO) Drugs Consumption CAGR by Region
2.2 Erythropoietin (EPO) Drugs Segment by Type
  2.2.1 Epoetin-alfa
  2.2.2 Darbepoetin-alfa
  2.2.3 Epoetin-beta
2.3 Erythropoietin (EPO) Drugs Consumption by Type
  2.3.1 Global Erythropoietin (EPO) Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Erythropoietin (EPO) Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Erythropoietin (EPO) Drugs Sale Price by Type (2013-2018)
2.4 Erythropoietin (EPO) Drugs Segment by Application
  2.4.1 Anemic indications
  2.4.2 Cancer
  2.4.3 Hematology
  2.4.4 Neurology
  2.4.5 Renal diseases
2.5 Erythropoietin (EPO) Drugs Consumption by Application
  2.5.1 Global Erythropoietin (EPO) Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Erythropoietin (EPO) Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Erythropoietin (EPO) Drugs Sale Price by Application (2013-2018)

3 GLOBAL ERYTHROPOIETIN (EPO) DRUGS BY PLAYERS

3.1 Global Erythropoietin (EPO) Drugs Sales Market Share by Players
  3.1.1 Global Erythropoietin (EPO) Drugs Sales by Players (2016-2018)
  3.1.2 Global Erythropoietin (EPO) Drugs Sales Market Share by Players (2016-2018)
3.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Players
  3.2.1 Global Erythropoietin (EPO) Drugs Revenue by Players (2016-2018)
  3.2.2 Global Erythropoietin (EPO) Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Erythropoietin (EPO) Drugs Sale Price by Players
3.4 Global Erythropoietin (EPO) Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Erythropoietin (EPO) Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Erythropoietin (EPO) Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ERYTHROPOIETIN (EPO) DRUGS BY REGIONS

4.1 Erythropoietin (EPO) Drugs by Regions
  4.1.1 Global Erythropoietin (EPO) Drugs Consumption by Regions
  4.1.2 Global Erythropoietin (EPO) Drugs Value by Regions
4.2 Americas Erythropoietin (EPO) Drugs Consumption Growth
4.3 APAC Erythropoietin (EPO) Drugs Consumption Growth
4.4 Europe Erythropoietin (EPO) Drugs Consumption Growth
4.5 Middle East & Africa Erythropoietin (EPO) Drugs Consumption Growth

5 AMERICAS

5.1 Americas Erythropoietin (EPO) Drugs Consumption by Countries
  5.1.1 Americas Erythropoietin (EPO) Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Erythropoietin (EPO) Drugs Value by Countries (2013-2018)
5.2 Americas Erythropoietin (EPO) Drugs Consumption by Type
5.3 Americas Erythropoietin (EPO) Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Erythropoietin (EPO) Drugs Consumption by Countries
  6.1.1 APAC Erythropoietin (EPO) Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Erythropoietin (EPO) Drugs Value by Countries (2013-2018)
6.2 APAC Erythropoietin (EPO) Drugs Consumption by Type
6.3 APAC Erythropoietin (EPO) Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Erythropoietin (EPO) Drugs by Countries
  7.1.1 Europe Erythropoietin (EPO) Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Erythropoietin (EPO) Drugs Value by Countries (2013-2018)
7.2 Europe Erythropoietin (EPO) Drugs Consumption by Type
7.3 Europe Erythropoietin (EPO) Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Erythropoietin (EPO) Drugs by Countries
  8.1.1 Middle East & Africa Erythropoietin (EPO) Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Erythropoietin (EPO) Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Erythropoietin (EPO) Drugs Consumption by Type
8.3 Middle East & Africa Erythropoietin (EPO) Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Erythropoietin (EPO) Drugs Distributors
10.3 Erythropoietin (EPO) Drugs Customer

11 GLOBAL ERYTHROPOIETIN (EPO) DRUGS MARKET FORECAST

11.1 Global Erythropoietin (EPO) Drugs Consumption Forecast (2018-2023)
11.2 Global Erythropoietin (EPO) Drugs Forecast by Regions
  11.2.1 Global Erythropoietin (EPO) Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Erythropoietin (EPO) Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Erythropoietin (EPO) Drugs Forecast by Type
11.8 Global Erythropoietin (EPO) Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Johnson & Johnson
  12.1.1 Company Details
  12.1.2 Erythropoietin (EPO) Drugs Product Offered
  12.1.3 Johnson & Johnson Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Johnson & Johnson News
12.2 Celltrion
  12.2.1 Company Details
  12.2.2 Erythropoietin (EPO) Drugs Product Offered
  12.2.3 Celltrion Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Celltrion News
12.3 Teva Pharmaceutical
  12.3.1 Company Details
  12.3.2 Erythropoietin (EPO) Drugs Product Offered
  12.3.3 Teva Pharmaceutical Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Teva Pharmaceutical News
12.4 Amgen
  12.4.1 Company Details
  12.4.2 Erythropoietin (EPO) Drugs Product Offered
  12.4.3 Amgen Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Amgen News
12.5 Roche
  12.5.1 Company Details
  12.5.2 Erythropoietin (EPO) Drugs Product Offered
  12.5.3 Roche Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Roche News
12.6 LG Life Sciences
  12.6.1 Company Details
  12.6.2 Erythropoietin (EPO) Drugs Product Offered
  12.6.3 LG Life Sciences Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 LG Life Sciences News
12.7 Biocon
  12.7.1 Company Details
  12.7.2 Erythropoietin (EPO) Drugs Product Offered
  12.7.3 Biocon Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Biocon News
12.8 Intas Pharmaceuticals
  12.8.1 Company Details
  12.8.2 Erythropoietin (EPO) Drugs Product Offered
  12.8.3 Intas Pharmaceuticals Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Intas Pharmaceuticals News
12.9 Sun Pharmaceutical
  12.9.1 Company Details
  12.9.2 Erythropoietin (EPO) Drugs Product Offered
  12.9.3 Sun Pharmaceutical Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Sun Pharmaceutical News
12.10 Dr. Reddy’s Laboratories
  12.10.1 Company Details
  12.10.2 Erythropoietin (EPO) Drugs Product Offered
  12.10.3 Dr. Reddy’s Laboratories Erythropoietin (EPO) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Dr. Reddy’s Laboratories News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Erythropoietin (EPO) Drugs
Table Product Specifications of Erythropoietin (EPO) Drugs
Figure Erythropoietin (EPO) Drugs Report Years Considered
Figure Market Research Methodolog